Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Exchange Rate Effect (2016 - 2025)

Historic Exchange Rate Effect for Accendra Health (ACH) over the last 14 years, with Q3 2025 value amounting to -$34000.0.

  • Accendra Health's Exchange Rate Effect fell 10311.93% to -$34000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $458000.0, marking a year-over-year decrease of 7018.23%. This contributed to the annual value of -$901000.0 for FY2024, which is 24698.21% down from last year.
  • Latest data reveals that Accendra Health reported Exchange Rate Effect of -$34000.0 as of Q3 2025, which was down 10311.93% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Accendra Health's Exchange Rate Effect registered a high of $2.3 million during Q4 2022, and its lowest value of -$3.2 million during Q2 2022.
  • For the 5-year period, Accendra Health's Exchange Rate Effect averaged around -$291894.7, with its median value being -$88000.0 (2023).
  • Per our database at Business Quant, Accendra Health's Exchange Rate Effect tumbled by 335000.0% in 2021 and then surged by 206718.75% in 2025.
  • Over the past 5 years, Accendra Health's Exchange Rate Effect (Quarter) stood at -$1.1 million in 2021, then skyrocketed by 308.75% to $2.3 million in 2022, then tumbled by 50.24% to $1.1 million in 2023, then crashed by 216.05% to -$1.3 million in 2024, then soared by 97.4% to -$34000.0 in 2025.
  • Its last three reported values are -$34000.0 in Q3 2025, $1.3 million for Q2 2025, and $542000.0 during Q1 2025.